Dexmedetomidine Bags Recalled for Lack of Sterility Assurance
CMC Enterprise Pharmacy is recalling 5,678 bags of Dexmedetomidine 400 mcg in NS 100 mL due to a lack of sterility assurance. The affected products were distributed in North Carolina.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, and the rubric specifies that FDA Class II recalls with hospitalization reports or significant injury reports are Severe. While the source does not explicitly state hospitalizations, the lack of sterility assurance in an IV medication is a significant hazard that aligns with the Severe criteria for Class II recalls involving potential serious harm.
Plain-English summary
CMC Enterprise Pharmacy is recalling 5,678 bags of Dexmedetomidine 400 mcg in NS 100 mL. The recall was initiated because the product lacks sterility assurance. The affected lots include EA141908, EA171909, EA211906, EA251908, EB041905, EB071907, EB151909, EC041906, EC111907, EC181908, and EC201907, with expiration dates ranging from April 14, 2019, to June 18, 2019.
The recall is classified as FDA Class II. The affected products were distributed in North Carolina. The source text does not specify the number of patients affected or report any illnesses or injuries.
Healthcare providers and consumers should stop using the affected lots and contact CMC Enterprise Pharmacy for further instructions or a refund.
The recalled product
- Product
- Dexmedetomidine 400 mcg in NS 100 mL bag, Made by: Enterprise Pharmacy, 4400 Golf Acres Drive, Bldg. J Suite E, Charlotte, NC, 28208.
- Manufacturer
- CMC Enterprise Pharmacy
- Category
- Drug — IV Medication
- Hazard
- Affected units
- 5,678
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (11)
- Lots: EA141908 Exp. 4/14/2019
- EA171909 Exp. 4/17/2019
- EA211906 Exp. 4/21/2019
- EA251908 Exp. 4/25/2019
- EB041905 Exp. 5/6/2019
- EB071907 Exp. 5/8/2019
- EB151909 Exp. 5/16/2019
- EC041906 Exp. 6/2/2019
- EC111907 Exp. 6/9/2019
- EC181908 Exp. 6/16/2019
- EC201907 Exp. 6/18/2019
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 32 recalled by CMC Enterprise Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 32 products in this recall →Related recalls
Same manufacturer · CMC Enterprise Pharmacy
See all →- SevereCMC Enterprise Pharmacy Recalls Oxytocin Bags Due to Sterility Concerns
FDA (Drugs) · 2019-05-01
- SevereCMC Enterprise Pharmacy Recalls Vancomycin Bags Due to Sterility Concerns
FDA (Drugs) · 2019-05-01
- SevereDiltiazem 250 mg IV Bags Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2019-05-01
- SevereCMC Enterprise Pharmacy Recalls Magnesium Sulfate Bags Due to Sterility Concerns
FDA (Drugs) · 2019-05-01
- SevereCMC Enterprise Pharmacy Recalls CefTRIAXone Syringes Due to Sterility Concerns
FDA (Drugs) · 2019-05-01
Same hazard · lack of sterility
See all →- SevereK.C. Pharmaceuticals Recalls Dry Eye Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Multiple Brands of Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Assurance Issues
FDA (Drugs) · 2026-09-30
- SevereGentle Eyes Lubricant Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
Similar recalls
- HighFDA Recalls OxyTOCIN IV Bags Due to Sterility Assurance Issues
FDA (Drugs) · 2023-08-09
- SevereDexpanthenol Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2018-11-07
- SevereMedical Center Pharmacy Recalls Gentamicin Bladder Irrigation Bags
FDA (Drugs) · 2020-04-08
- SevereGentamycin Injection Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2014-03-12
- HighNeonatal TPN Starter Bags Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2023-08-09
- SevereBaptist Health Recalls Clindamycin IV Bags Due to Sterility Concerns
FDA (Drugs) · 2016-06-08